Clinical Trials Browser

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Prostatic Neoplasms, Castration-Resistant

NCT07517510 2026-04-08

HVA-MPAL

Phase 2 Enrolling by invitation

40 enrolled

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute

NCT07515430 2026-04-07

The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia

Enrolling by invitation

138 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06795126 2026-03-27

Little NIRVANA for Pediatric Pain and Anxiety

Phase NA Enrolling by invitation

130 enrolled

LymphoidOther hematologic neoplasm

Anxiety Disorders, Pain, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Pain

NCT06211413 2026-03-23

SENTINEL

Enrolling by invitation

50 enrolled

LymphoidOther hematologic neoplasm

Atrial Fibrillation, Hypertension, Leukemia, Lymphocytic, Chronic, B-Cell, Cardiotoxicity

NCT07474051 2026-03-16

PERSIST

Enrolling by invitation

178 enrolled

GenitourinaryLymphoidOther hematologic neoplasm

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05332054 2026-03-12

LTFS

Enrolling by invitation

150 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT06773936 2026-03-04

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Phase 2 Enrolling by invitation

55 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05041309 2026-02-25

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Enrolling by invitation

1,000 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT07383298 2026-02-03

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

Enrolling by invitation

100 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

Natural History Study of Early Life Exposures in Agriculture (ELEA)

Biology Studies of Hematologic Cancers

Screening for Hematology Branch Protocols

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

VEN+IDAC vs IDAC in AML

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

HVA-MPAL

The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia

Little NIRVANA for Pediatric Pain and Anxiety

SENTINEL

PERSIST

LTFS

Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase